Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07126717) titled 'Acute Effects of Zynamite(R) S in Cognitive Function and Mood' on Aug. 11.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Nektium Pharma SL
Condition:
Cognitive Performance
Mood
Intervention:
Dietary Supplement: Placebo
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: May 12, 2025
Target Sample Size: 88
Countries of Recruitment:
Spain
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07...